CIK 0000882095 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | |
|---|---|---|
| Revenue (USD) | 29.4 B | 27.3 B |
| Net income (USD) | 8.5 B | 4.6 B |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-16 | 4 | FORM 4 | 2026-10-15 |
| 2026-10-16 | 4 | FORM 4 | 2026-10-15 |
| 2026-10-15 | 144 | 144 | |
| 2026-10-15 | 144 | 144 | |
| 2026-10-02 | 4 | FORM 4 | 2026-10-01 |
| 2026-09-23 | 4 | FORM 4 | 2026-09-22 |
| 2026-09-16 | 4 | FORM 4 | 2026-09-15 |
| 2026-09-16 | 4 | FORM 4 | 2026-09-15 |
| 2026-09-15 | 144 | 144 | |
| 2026-09-15 | 144 | 144 | |
| 2026-09-11 | 4 | FORM 4 | 2026-09-10 |
| 2026-09-11 | 4 | FORM 4 | 2026-09-10 |
| 2026-09-11 | 4 | FORM 4 | 2026-09-10 |
| 2026-09-11 | 4 | FORM 4 | 2026-09-10 |
| 2026-09-11 | 4 | FORM 4 | 2026-09-10 |
| 2026-09-02 | 4 | FORM 4 | 2026-09-01 |
| 2026-08-27 | 4 | FORM 4 | 2026-08-26 |
| 2026-08-26 | 144 | 144 | |
| 2026-08-26 | N-PX | N-PX | 2026-06-30 |
| 2026-08-21 | 4 | FORM 4 | 2026-08-20 |
| 2026-08-20 | 144 | 144 | |
| 2026-08-18 | 4 | FORM 4 | 2026-08-17 |
| 2026-08-18 | 4 | FORM 4 | 2026-08-17 |
| 2026-08-17 | 144 | 144 | |
| 2026-08-17 | 144 | 144 |
Forms on file (last 1,000): 4 559, 144 91, 8-K 88, 3 30, SC 13G/A 29, 10-Q 26, SC TO-T/A 18, SC 13G 16. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=GILD (0.002 USD), /gw/filings/filings?ticker=GILD&form=8-K, /gw/filings/facts?ticker=GILD&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange